GERUSSI, ALESSIO

GERUSSI, ALESSIO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 97 (tempo di esecuzione: 0.011 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Established cirrhosis at the time of diagnosis predicts adverse outcome in autoimmune hepatitis: A retrospective cohort study 02 - Intervento a convegno 2017 Gerussi, A +
Gender differences in liver disease and the drug-dose gender gap 01 - Articolo su rivista 2017 Gerussi A. +
Elevated baseline igg is a risk factor for on-treatment flares of autoimmune hepatitis in patients in biochemical remission 02 - Intervento a convegno 2017 Gerussi, A. +
The role of ethnicity in autoimmune hepatitis 02 - Intervento a convegno 2017 Gerussi, A. +
EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) 02 - Intervento a convegno 2018 Gerussi, A +
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 01 - Articolo su rivista 2018 Carbone, MarcoBernuzzi, FrancescaCristoferi, LauraMalinverno, FedericaGerussi, AlessioInvernizzi, PietroInvernizzi, PietroMalinverno, FedericaBernuzzi, FrancescaGRIECO, ANTONIO +
Black Ethnicity Affects the Clinical Presentation and Outcome in Autoimmune Hepatitis 02 - Intervento a convegno 2018 Gerussi, A +
NON ADHERENCE TO AASLD - EASL GUIDELINES FOR THE MANAGEMENT OF HEPATOCELLULAR CARCINOMA DOES NOT TRANSLATE INTO WORSE OUTCOMES 02 - Intervento a convegno 2018 Gerussi, A +
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 02 - Intervento a convegno 2018 Gerussi, A +
Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers 01 - Articolo su rivista 2018 Gerussi, AlessioCarbone, MarcoInvernizzi, Pietro +
The immunobiology of female predominance in primary biliary cholangitis 01 - Articolo su rivista 2018 Gerussi, AlessioCristoferi, LauraCarbone, MarcoInvernizzi, Pietro +
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 02 - Intervento a convegno 2018 Carbone, MRonca, VCristoferi, LMalinverno, FGerussi, AInvernizzi, P +
Incomplete normalization of transaminases at 18 months is the most important predictor for failure of biochemical response in autoimmune hepatitis 02 - Intervento a convegno 2018 Gerussi, A +
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 02 - Intervento a convegno 2019 Gerussi, A +
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 02 - Intervento a convegno 2019 Gerussi, ACarbone, MRonca, VCristoferi, LMalinverno, FInvernizzi, P +
Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis 02 - Intervento a convegno 2019 Gerussi, A +
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 02 - Intervento a convegno 2019 Rebora, PaolaBernuzzi, FrancescaGerussi, AlessioValsecchi, Maria GraziaCarbone, MarcoInvernizzi, Pietro +
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 01 - Articolo su rivista 2019 Gerussi, AlessioInvernizzi, Pietro +
Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 01 - Articolo su rivista 2019 Rebora, PBernuzzi, FGerussi, AValsecchi, MGCarbone, MInvernizzi, P +
ANTITUMOR ACTIVITY OF A NOVEL FGFR INHIBITOR IN INTRAHEPATIC CHOLANGIOCARCINOMA 01 - Articolo su rivista 2019 Correnti, MForti, ERovida, EGerussi, AInvernizzi, P +